13
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Treatment of Massive Hemorrhage after Renal Biopsy with Percutaneous Arterial Obliteration

      case-report

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Severe perirenal hemorrhage is a major, although rare, postbiopsy complication. We report a case of a 48-year-old man with a postbiopsy massive bleeding from a ramification of the renal artery supplying the lower pole of the left kidney. Treatment consisted of complete obliteration of the bleeding vessel by helding a percutaneous catether in wedge position during a renal arteriographyc study. Our case shows that percutaneous arterial obliteration is a successful procedure in treating postbiopsy renal hemorrhage, representing an effective alternative to surgical therapy.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1988
          1988
          09 December 2008
          : 50
          : 4
          : 376-377
          Affiliations
          Departments of aNephrology and bRadiology, Second Faculty of Medicine, Naples, Italy
          Article
          185207 Nephron 1988;50:376–377
          10.1159/000185207
          3237279
          6f92f96b-224c-4ab8-a06c-21297ba21c5a
          © 1988 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 05 February 1988
          Page count
          Pages: 2
          Categories
          Case Report

          Cardiovascular Medicine,Nephrology
          Renal biopsy,Hemorrhage,Percutaneous arterial obliteration
          Cardiovascular Medicine, Nephrology
          Renal biopsy, Hemorrhage, Percutaneous arterial obliteration

          Comments

          Comment on this article